EP Patent

EP3023424B1 — Quinine compounds, and optical isomers, preparation method and medical use thereof

Assigned to Beijing Shuobai Pharmaceutical Co Ltd · Expires 2019-02-27 · 7y expired

What this patent protects

Patent listed against Arnuity Ellipta.

Drugs covered by this patent

Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings

Patent Metadata

Patent number: EP3023424B1
Jurisdiction: EP
Classification: —
Expires: 2019-02-27
Drug substance claim: No
Drug product claim: No
Assignee: Beijing Shuobai Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.